2 0 1 6
S C I E N T I F I C
S E S S I O N S P R O G R A M
4:00 PM - 5:30 PM
Concurrent Session 34: How Much is Too Much? Assessing Risk Prior to MCS (Salons 2-3) (MC S, HTX, NHSAH)
CHAIRS: Shashank S Desai, MD and Yuriy Pya, MD 4:00 PM
(274) Accuracy of Seattle Heart Failure Model and HeartMate II Risk Score in NonInotrope Dependent Advanced Heart Failure Patients: Insights from the ROADMAP Study
4:15 PM
(275) Physician Prediction of Outcomes in Ambulatory Patients with Advanced Heart Failure
4:30 PM
(276) Effect of Body Mass Index on Outcomes of Heart Transplant Candidates Supported by Continuous-Flow Left Ventricular Assist Devices (CF-LVADs)
4:45 PM
(277) Red Cell Distribution Width (RDW) Predicts 90-Day Mortality in ContinuousFlow Left Ventricular Assist Device (CF-LVAD) Patients
5:00 PM
(278) Heart Failure Etiology Influences Outcomes after Continuous-Flow LVAD Implantation
5:15 PM
(279) Survival Following Orthotopic Heart Transplantation in Bridge-to-Transplant Heartware HVAD versus Heartmate II Patients
1 64
F R I DAY April 29, 2016